7th Annual Spring to Life Conference on Lung Cancer

Albany, NY | April 18, 2020

Proudly Hosted by New York Oncology Hematology, PC

Proudly Hosted by New York Oncology Hematology

DATE/LOCATION

April 18, 2020
Marriott Albany
189 Wolf Road
Albany, NY 12205

Next quote »

"Identification of molecular drivers has resulted in tailored treatments for our patients with non-small cell lung cancer which are not only more effective, but less toxic. It is essential the community oncologist have a keen knowledge of the most current precision testing techniques and incorporate newer therapies to provide state-of-the-art care to patients close to home."

-Makenzi Evangelist, M.D., New York Oncology Hematology

“The landscape of lung cancer with new biomarkers, immunotherapies, and targeted therapies is constantly evolving, and it is a challenge for the community oncologist to integrate and apply this new knowledge in daily clinical practice. Accessible continuing education forums are crucial to support this rapid evolution of cancer care."

-Nischala Ammannagari, M.D., New York Oncology Hematology

Registration

Please click here if you would like to be notified when registration is open. We hope to see you in 2020!

S2L | Registration HCP

If you are human, leave this field blank.

First Name *

Last Name

Title Title

Specialty

Institution *

Address *

2nd Address

City *

State *

ZIP *

Phone

I plan to attend the following *

7:00am – 2:45pm General Session

1:00pm – 12:00pm Optional CME Lunch Symposium**

3:00pm – 5:00pm Patient-Centered Session

NOTICE°

** NOTICE ** 
You have selected the optional lunch session. Our team will contact you prior to the session to announce the topic and speaker.

How did you hear about the conference? * How did you hear about the conference?

reCAPTCHA

PROGRAM OVERVIEW

The focus of the 2020 Spring to Life Conference is Lung Cancer. New York Oncology Hematology (NYOH) has identified an ongoing unmet need for medical education in the area of lung cancer. To meet this need, NYOH, in collaboration with The University of Chicago Pritzker School of Medicine, myMedEd, Inc. and a panel of expert faculty from the academic, research, and community practice settings, developed an accredited, multi-supported, ½ -day educational conference. This is the seventh of these annual conferences that include programming for cancer clinicians.

EDUCATIONAL GOAL

The purpose of this conference is to educate practitioners and update their knowledge of existing and emerging therapies for the management of patients with lung cancer.

TARGET AUDIENCE

The target audience for this conference is medical oncologists, radiation oncologists, surgical oncologists, thoracic surgeons, pulmonologists, radiologists, interventional radiologists, pathologists, oncology nurses, advanced practice providers, family and primary care practitioners, allied health professionals, and any other individuals with an interest in the care of patients with lung cancer.

LEARNING OBJECTIVES

After completing this activity, participants will be able to:

Describe current and evolving management strategies for patients with localized and locally advanced, non-small cell lung cancer.
Identify best practices in biomarker testing and the utilization of biomarkers to drive treatment decisions for patients with lung cancer.
Explain the application of targeted therapy and immunotherapy in the treatment of NSCLC.
Outline the clinical trial data on the use of molecular drivers in the management of patients with advanced, non-small cell lung cancer.
Summarize current and emerging strategies in the management of patients with advanced, non-small cell lung cancer without driver mutations.

DOWNLOAD AGENDA

PLANNING COMMITTEE

Ira Zackon, MD (Chair)

Medical Hematology and Oncology Director
NYOH Hematology Stem Cell Transplant Program
Hematologist/Oncologist NYOH
Clinical Assistant Professor
Albany Medical College
Albany, NY

Makenzi Evangelist, MD

Medical Oncologist/Hematologist
NYOH Albany Cancer Center
Albany, NY

Nischala Ammannagari, MD

Medical Oncologist/Hematologist
NYOH Albany Cancer Center
Albany, NY

Guest Faculty

Abhinav Agrawal, MD

Interventional Pulmonology
The University of Chicago Medicine
Chicago, IL

Jamie Chaft, MD

Associate Attending Physician
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, NY

Ibiayi Dagogo-Jack, MD

Thoracic Oncologist
Massachusetts General Hospital
Boston, MA

Paul K. Paik, MD

Clinical Director, Thoracic Oncology Service
Associate Attending Physician
Memorial Sloan Kettering Cancer Center
New York, NY

Faculty

Justin Juliano, MD

Radiation Oncologist
New York Oncology Hematology
Albany, NY

Michael D. Robek, PhD

Professor
Department of Immunology & Microbial Disease
Albany Medical College
Albany, NY

Stephen H. Wrzesinski MD, PhD

Director of Immunooncology and Cellular Therapies
New York Oncology Hematology
Clinical Assistant Professor of Medicine
Albany Medical Center
Albany, NY

Ira Zackon, MD (Chair)

Medical Hematology and Oncology Director
NYOH Hematology Stem Cell Transplant Program
Hematologist/Oncologist NYOH
Clinical Assistant Professor
Albany Medical College
Albany, NY

Venue

Marriott Albany
189 Wolf Road
Albany, NY 12205
518-458-8444

Overnight accommodations at the Marriott Albany are offered at a special rate of $129/night. Hotel rooms are blocked for the night of April 17, 2020, only. The hotel will extend the negotiated rate to the nights before and after the conference based upon availability.

You may also call the hotel directly to make your reservation at 518-458-8444 and mention Group Code: Med Ed S2L.

Make your reservation

- Reservations must be made by March 27, 2020, to receive the special rate.
- Complimentary parking is available.
- Event staff will be glad to assist you with any special needs (physical, dietary, etc.). Contact us

Host

The 7th Annual Spring to Life™ Conference on Lung Cancer is proudly hosted by
New York Oncology Hematology, PC

ACCREDITATION

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the ACCME through the joint providership of The University of Chicago Pritzker School of Medicine, New York Oncology Hematology, PC, and myMedEd, Inc. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME, please consult your professional licensing board.

Assurance of Balanced, Unbiased, and Fair Content:

It is the policy of The University of Chicago Pritzker School of Medicine to ensure balance, independence, objectivity, and scientific rigor in all its individually provided or jointly provided educational activities. Individuals who are in a position to control the content of any educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Mechanisms to ensure that presentations are free from commercial bias are in place. Faculty will also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.

This Activity Is Planned By myMedEd, Inc.

Educational Partner

Accredited Provider:

Accredited Provider

Educational Partner

This Activity Is Planned By myMedEd, Inc.